DeNova Research   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Chicago IL United States (2007)

Organization Overview

First Clinical Trial
2008
NCT00765375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

DeNova Research | DeNova Research/ Chicago Center for Facial Plastic Surgery

Active Ingredients

Drugs in Phase 4 Trials (1)

alveograf (1 trial)

Drugs in Phase 2 Trials (4)

human fibrin (1 trial)

incobotulinumtoxinA (Xeomin) (1 trial)

rimabotulinumtoxinB (Myobloc) (2 trials)

sodium chloride (3 trials)

Drugs in Phase 1 Trials (2)

hyaluronic acid (2 trials)

onabotulinumtoxinA (Botox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Congenital Abnormalities (Phase 1)

Rosacea (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 7